AXSOME THERAPEUTICS, INC. Long-Term Debt, Maturity, Remainder of Fiscal Year
AXSOME THERAPEUTICS, INC. (AXSM) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $2.67 million as of 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2020-08-10
- 2020-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $2.67M.
- 2020-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $2.67M.
- 2018-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $833.33K.
- 2018-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $1.67M.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2020-06-30 | $2.67M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $2.67M 10-Q · filed 2020-05-11 |
| 2018-09-30 | $833.33K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $1.67M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $2.50M 10-Q · filed 2018-05-08 |
| 2017-09-30 | $277.78K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $277.78K 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |